Latest Breaking News On - Regulatory science division - Page 1 : comparemela.com

Shionogi Begins Phase 3 Study in Japan of Akili s Digital Treatment in Children with ADHD

Shionogi Begins Phase 3 Study in Japan of Akili s Digital Treatment in Children with ADHD
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesTakeki ueharaJulie dicarloShionogi co ltdRegulatory science division of shionogi co ltdLancet digital healthDrug administrationCapital suvretta holdings corpDrug developmentCorporate officerSenior vice presidentRegulatory science divisionChief medical officerLancet digitalSocial capital suvretta holdingsRegistration statement

PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan

PureTech Founded Entity Akili Announces Phase 3 Study of Digital Treatment in Children with ADHD Begun by Shionogi in Japan
apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.

United statesTakeki ueharaRob winderBen atwellNichole sarkisRegulatory science division of shionogi co ltdShionogi co ltdDrug administrationDrug developmentAkili interactive labs incPuretech healthLancet digital healthCapital suvretta holdings corpTech healthFounded entityAkili interactive labs